Login / Signup

Is there an increased risk of severe COVID-19 among patients with systemic lupus erythematosus treated with anifrolumab?

Paul BreillatAlexis MathianFlore RozenbergAmélie DutheilAnnick BarbaudZahir AmouraFrançois Chasset
Published in: Lupus (2023)
Keyphrases
  • coronavirus disease
  • sars cov
  • early onset
  • respiratory syndrome coronavirus
  • newly diagnosed
  • drug induced